| [1] |
Wang Yihan, Qin Xuyan, Han Xuanze, Wang Yingjie, Gao Feifei, Chen Chunhong, Zhang Lingnan, Zhang Fang.
Efficacy and safety of rivaroxaban therapy in elderly patients with non-valvular atrial fibrillation who had a HASBLED score≥3
[J]. Clinical Focus, 2024, 39(2): 121-124.
|
| [2] |
.
[J]. Clinical Focus, 2024, 39(2): 168-171.
|
| [3] |
Zhang Fang, Zhang Yichao, Jia Xinwei, Li Jianlong, Chen Chunhong.
Analysis of one-year follow-up results of ≥75-year-old atrial fibrillation inpatients with high CHA2DS2-VASc score
[J]. Clinical Focus, 2023, 38(2): 117-120.
|
| [4] |
Li Weiwei, Li Yanan.
Left atrial volume index predicts atrial fibrillation recurrence after radiofrequency ablation: A meta-analysis
[J]. Clinical Focus, 2022, 37(11): 965-968.
|
| [5] |
.
[J]. Clinical Focus, 2022, 37(10): 946-949.
|
| [6] |
Zhang Haifu, Ye Xiangqing, Chen Zhexu, Chen Shijian, Yang Dong, Zhang Xingwei.
Effects of moderate exercise on the prognosis of patients with atrial fibrillation:A systematic review and Meta-analysis
[J]. Clinical Focus, 2022, 37(6): 485-489.
|
| [7] |
Zhao Meili, Xiao Liyuan, Liu Lin, Kang Chao, Zhang Qiuxiang.
Correlation between NT-proBNP, hs-CRP, left atrium diameter and chronic heart failure concurrent with atrial fibrillation
[J]. Clinical Focus, 2021, 36(5): 412-415.
|
| [8] |
Lu Yuqin, Li Yingdong, Liu Kai.
Role of serum MMP-1, MMP-3, TIMP-1 and Hcy levels in patients with hypertension complicated with atrial fibrillation
[J]. Clinical Focus, 2020, 35(11): 976-979.
|
| [9] |
Guo Xueyuan, Ma Changsheng.
Atrial fibrillation treatment: present state and future directions
[J]. Clinical Focus, 2016, 31(1): 7-9.
|
| [10] |
Qi Shuyuan,Tian Ying.
Role of percutaneous left atrial appendage occlusion in stroke prevention for nonvalvular atrial fibrillation
[J]. Clinical Focus, 2016, 31(1): 10-13.
|
| [11] |
Xue Li, Cai Heng.
Anticoagulation advance in atrial fibrillation
[J]. Clinical Focus, 2016, 31(1): 14-18.
|
| [12] |
Xie Ruiqin, Yin Guangli, Yang Yingtao.
The status and advances of radiofrequency catheter ablation for atrial fibrillation
[J]. Clinical Focus, 2016, 31(1): 19-21.
|
| [13] |
Liu Hongbin, Wang Xiaoyan, Zhang Zhigang, Ji Zhenguo.
Treatment of acute atrial fibrillation
[J]. Clinical Focus, 2016, 31(1): 22-26.
|
| [14] |
Qi Shuying, Yuan Xiaohong.
Drug therapy of atrial fibrillation with organic heart disease
[J]. Clinical Focus, 2016, 31(1): 27-29.
|
| [15] |
Ding Chao.
Progress of treatment strategy in atrial fibrillation with non-structural heart disease
[J]. Clinical Focus, 2016, 31(1): 30-33.
|
